12 Health Care Stocks Moving In Thursday's After-Market Session

Gainers

  • Magenta Therapeutics MGTA stock rose 41.3% to $0.8 during Thursday's after-market session. Trading volume for this security closed at 2.9 million, accounting for 164.9% of its average full-day volume over the last 100 days. The company's market cap stands at $48.3 million.
  • INVO Bioscience INVO stock rose 14.79% to $0.69. The market value of their outstanding shares is at $8.3 million.
  • Nymox Pharmaceutical NYMX stock increased by 11.11% to $0.5. The market value of their outstanding shares is at $45.2 million.
  • Aspira Womens Health AWH stock increased by 10.9% to $0.49. Aspira Womens Health's trading volume hit 117.9K shares by close, accounting for 53.9% of its average volume over the last 100 days. The market value of their outstanding shares is at $60.8 million.
  • Processa Pharma PCSA stock moved upwards by 5.0% to $1.05. The market value of their outstanding shares is at $16.7 million.
  • Plus Therapeutics PSTV stock moved upwards by 5.0% to $0.43. The company's market cap stands at $14.4 million.

Losers

  • Avalo Therapeutics AVTX shares declined by 23.4% to $3.08 during Thursday's after-market session. The market value of their outstanding shares is at $28.9 million.
  • Cellectis CLLS shares fell 17.18% to $2.7. The company's market cap stands at $123.0 million.
  • SILO Pharma SILO stock fell 12.42% to $2.68. This security traded at a volume of 75.5K shares come close, making up 17.0% of its average volume over the last 100 days. The market value of their outstanding shares is at $8.4 million.
  • MEI Pharma MEIP shares declined by 7.96% to $0.31. The market value of their outstanding shares is at $40.8 million.
  • Biophytis BPTS stock declined by 7.79% to $0.65. Trading volume for this security closed at 11.8 million, accounting for 9508.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $13.3 million. As per the news, the H1 earnings report came out 2 days ago.
  • Virpax Pharmaceuticals VRPX shares declined by 7.41% to $1.0. The company's market cap stands at $11.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!